Lifeward Ltd. 得到林业发展局对ReWalk 7 exoskeleton的批准,帮助脊髓损伤患者走路。 Lifeward Ltd. gets FDA approval for ReWalk 7 exoskeleton, aiding spinal cord injury patients to walk.

Lifeward有限公司获得林业发展局对其新的ReWalk 7 exoskeleton装置的许可,该装置帮助有脊髓损伤的人站立和行走。 Lifeward Ltd. received FDA clearance for its new ReWalk 7 exoskeleton device, which helps individuals with spinal cord injuries stand and walk. 该设备包括新的功能和升级。 The device includes new features and upgrades. 活生生的计划是 在美国发射ReWalk 7 一旦它获得。 Lifeward plans to launch the ReWalk 7 in the U.S. as soon as it is available. 这一里程碑是继之前的进展之后,例如FDA对ReWalk 6.0的批准以及2024年国家退款政策的批准. This milestone follows previous advancements like FDA clearance for the ReWalk 6.0 and national reimbursement policy approval in 2024.